Search results for CD276

Cluster of Differentiation 276 (CD276) Antibody, Abbexa, abx129653

Cluster Of Differentiation 276 Antibody is a Rabbit Polyclonal against Cluster Of Differentiation 276.

Cluster of Differentiation 276 (CD276) Antibody, Abbexa, abx111473

Cd276 Molecule Antibody is a Rabbit Polyclonal antibody against Cd276 Molecule.

Anti-CD276 antibody [EPR27429-173], Abcam, AB313380

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD276 antibody [MM0104-20J12], Abcam, AB89133

Anti-CD276 antibody [SP206], prediluted, Abcam, AB228178

PE Anti-CD276 antibody [06], Abcam, AB275661

PE Anti-CD276 antibody [EPNCIR122], Abcam, AB314419

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-CD276 antibody [SP206], Abcam, AB320520

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Cluster of Differentiation 276 (CD276) Antibody, Abbexa, abx027013

Costimulatory B7 molecules (e.g., B7-1, or CD80; MIM 112203) signal through CD28 (MIM 186760) family molecules such as CD28, CTLA4 (MIM 123890), and ICOS (MIM 604558).

Anti-CD276/B7-H3 Antibody (R2H83), AntibodySystem, RMJ04001